ANELLI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.140
AS - Asia 1.082
EU - Europa 944
SA - Sud America 273
AF - Africa 40
OC - Oceania 2
Totale 5.481
Nazione #
US - Stati Uniti d'America 3.086
SG - Singapore 479
CN - Cina 238
BR - Brasile 219
DE - Germania 198
SE - Svezia 169
RU - Federazione Russa 144
HK - Hong Kong 116
FR - Francia 97
IT - Italia 89
VN - Vietnam 83
GB - Regno Unito 75
FI - Finlandia 73
BE - Belgio 31
IN - India 31
AR - Argentina 25
CA - Canada 24
BD - Bangladesh 20
MX - Messico 19
UA - Ucraina 17
IQ - Iraq 14
PK - Pakistan 13
TR - Turchia 13
ZA - Sudafrica 13
CI - Costa d'Avorio 12
ID - Indonesia 12
IR - Iran 10
JP - Giappone 10
CO - Colombia 8
PL - Polonia 8
CZ - Repubblica Ceca 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AT - Austria 6
CL - Cile 6
ES - Italia 6
EC - Ecuador 5
MA - Marocco 5
NL - Olanda 5
PH - Filippine 5
PY - Paraguay 5
CR - Costa Rica 4
MY - Malesia 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
LT - Lituania 3
NP - Nepal 3
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MP - Marianne Settentrionali, isole 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 5.481
Città #
Ashburn 338
Fairfield 315
Chandler 286
Singapore 275
Woodbridge 257
Houston 168
Seattle 166
San Jose 152
Ann Arbor 150
Nyköping 141
Cambridge 119
Hong Kong 114
Beijing 107
Wilmington 102
Dallas 57
Munich 57
New York 55
Los Angeles 47
Jacksonville 46
Lawrence 39
Roxbury 39
Lauterbourg 33
Moscow 33
Brussels 31
Bari 30
Helsinki 29
Des Moines 27
Turku 27
Dearborn 26
Ho Chi Minh City 26
Inglewood 26
Brooklyn 25
Nanjing 24
San Diego 20
Buffalo 19
Santa Clara 19
London 18
Paris 17
São Paulo 15
Hanoi 13
Princeton 13
Abidjan 12
San Francisco 12
Frankfurt am Main 10
Montreal 10
Orem 10
Poplar 10
Tokyo 10
Denver 9
Redwood City 9
Belo Horizonte 8
Boardman 8
Hebei 8
Brasília 7
Chicago 7
Dong Ket 7
Jakarta 7
Johannesburg 7
Lahore 7
Mumbai 7
Shanghai 7
Toronto 7
Warsaw 7
Atlanta 6
Boston 6
Council Bluffs 6
Milan 6
Nanchang 6
Tashkent 6
Ardabil 5
Falkenstein 5
Haiphong 5
Mexico City 5
Nuremberg 5
Ottawa 5
Vienna 5
Amsterdam 4
Changsha 4
Chennai 4
Da Nang 4
Guangzhou 4
Hefei 4
Jinan 4
Kunming 4
Querétaro 4
Quito 4
Rio de Janeiro 4
Shenyang 4
Tianjin 4
Washington 4
Augusta 3
Baghdad 3
Baku 3
Bauru 3
Benito Juarez 3
Buenos Aires 3
Cape Town 3
Curitiba 3
Detroit 3
Goiânia 3
Totale 3.844
Nome #
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 204
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 188
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 183
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 177
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 176
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 169
Early changes of articular cartilage, synovial membrane and subchondral bone in an experimental model of goat osteoarthrtitis 167
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 165
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 162
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 162
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 161
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 155
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 155
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 153
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 153
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 150
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 148
Old and new antirheumatic drugs and the risk of hepatotoxicity 147
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 142
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 140
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 140
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 134
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 131
Management of Small Vessel Vasculitides 129
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 129
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 124
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 121
Giant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab 116
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 115
Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis 113
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 108
EARLY CHANGES OF ARTHICULAR CARTILAGE, SYNOVIAL MEMBRANE AND SUBCHONDRAL BONE IN AN EXPERIMENTAL MODEL OF GOAT OSTEOARTHRITIS 106
OPG-RANKL system and Osteopontin in a postmenopausal women population. ANNALS OF THE RHEUMATIC DISEASES 102
null 101
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 99
null 97
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study 93
Temporomandibular Disorders and Oral Features in Early Rheumatoid Arthritis Patients: An Observational study. 86
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 78
La qualità di vita nelle poliartriti croniche. Studio preliminare 66
Influence of TNF- α inhibition on oxidative stress of rheumatoid arthritis patients 64
L'obésité diminue le maintien thérapeutique des traitements biologiques de seconde ligne après échec d'un anti-TNF de première ligne au cours de la polyarthrite rhumatoïde 64
Disease activity assessment for juvenile idiopathic arthritis in transitional care 26
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors 16
Totale 5.615
Categoria #
all - tutte 22.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.559


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022362 20 24 8 13 18 31 10 19 19 30 57 113
2022/2023659 72 106 46 66 71 83 16 78 88 5 17 11
2023/2024154 8 35 10 17 15 41 2 5 0 3 2 16
2024/2025870 18 16 63 25 13 74 91 107 41 51 135 236
2025/20261.671 276 88 104 192 275 104 174 47 188 171 38 14
Totale 5.615